ClinicalTrials.Veeva

Menu

Hypofractionated PBI After BCS for Low-risk Breast Cancer Patients

Fudan University logo

Fudan University

Status

Completed

Conditions

Breast Cancer

Treatments

Radiation: hypofractionated partial breast irradiation

Study type

Interventional

Funder types

Other

Identifiers

NCT03411174
FDRT-BC003

Details and patient eligibility

About

The study was designed to evaluate the feasibility and safety of hypofractionated partial breast irradiation after breast-conserving surgery for low-risk breast cancer patients.

Full description

A total dose of 40.05Gy in 15 fractions was delivered to the tumor bed for each eligible breast cancer patients. The endpoints including loco-regional recurrence, cosmetic outcomes, and toxicities, were evaluated after treatment.

Enrollment

220 patients

Sex

Female

Ages

50 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Female
  • Age≥ 50 years
  • Treated with breast conversing surgery and sentinel lymph node biopsy or axillary lymph node dissection
  • Negative surgical margins
  • Pathologically confirmed invasive breast cancer
  • A pathological T1N0M0 tumor -IHC: ER+/PR+/HER2-
  • Tumor bed is labeled with Titanium clips
  • Received adjuvant hormonal treatment
  • No adjuvant chemotherapy
  • ECOG:0-1
  • Written informed consent.

Exclusion criteria

  • Age<50 years
  • KPS<70
  • Treated with neoadjuvant chemotherapy
  • Treated or being treated with chemotherapy
  • With severe comorbidity
  • Previous breast cancer or other malignant tumor history
  • Previous radiotherapy for breast or thorax
  • Medical contraindication for radiotherapy
  • Pregnant or nursing

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

220 participants in 1 patient group

HF-PBI
Experimental group
Description:
Hypofractionated partial breast irradiation was delivered to the tumor bed areas for low recurrence risk breast cancer patients, with prescription dose 40Gy in 15 fractions in 3 weeks.
Treatment:
Radiation: hypofractionated partial breast irradiation

Trial contacts and locations

1

Loading...

Central trial contact

Jinli Ma, MD,PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems